Rho GTPase 8, also known as Rho8, is a member of the Rho family of small GTPases that play essential roles in regulating various cellular processes, including cytoskeletal dynamics, cell migration, and cell polarity. Rho8 functions as a molecular switch, cycling between an active GTP-bound state and an inactive GDP-bound state, to exert its regulatory influence on downstream signaling pathways. In particular, Rho8 is implicated in the regulation of actin cytoskeleton organization and dynamics, serving as a key mediator of cellular morphogenesis and cell migration processes. Additionally, Rho8 has been implicated in the regulation of intracellular vesicle trafficking and membrane dynamics, further highlighting its diverse functions in cellular physiology.
The activation of Rho8 is tightly regulated by a complex network of regulatory proteins and signaling pathways. Upon extracellular stimulation by various growth factors, cytokines, or environmental cues, such as mechanical stress or cell-cell interactions, upstream signaling molecules, such as guanine nucleotide exchange factors (GEFs), facilitate the exchange of GDP for GTP on Rho8, leading to its activation. This GTP-bound active form of Rho8 then interacts with downstream effector proteins, such as Rho kinases (ROCKs) and Diaphanous-related formins (DRFs), to initiate signaling cascades that regulate actin cytoskeleton dynamics and cellular responses. Additionally, post-translational modifications, including prenylation and phosphorylation, further modulate Rho8 activity and localization within the cell, fine-tuning its functions in various cellular processes. Overall, elucidating the mechanisms underlying Rho8 activation provides critical insights into the regulation of cytoskeletal dynamics and cellular morphogenesis, with implications for understanding the pathogenesis of diseases characterized by dysregulated cell migration and morphogenesis.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
A protein kinase C inhibitor, could indirectly affect Rho 8 activity by altering downstream signaling pathways. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
A broad-spectrum protein kinase inhibitor, potentially influencing Rho 8 through changes in kinase-mediated signaling pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C, potentially influencing Rho 8 activity through altered signaling cascades. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK inhibitor, can indirectly modulate Rho 8 activity by affecting cytoskeletal dynamics. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Known to modulate GSK-3β and other signaling pathways, potentially affecting Rho 8 activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor, could modulate signaling pathways affecting Rho 8 activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
A p38 MAPK inhibitor, potentially impacting signaling pathways that modulate Rho 8 activity. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Might influence Rho GTPase signaling pathways, indirectly affecting Rho 8. | ||||||
Sodium nitroprusside dihydrate | 13755-38-9 | sc-203395 sc-203395A sc-203395B | 1 g 5 g 100 g | $43.00 $85.00 $158.00 | 7 | |
Can modulate various signaling pathways, potentially affecting Rho 8's role in vascular functions. | ||||||